- 1.Treede, R. D., et al. (2008). Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology, 70(18), 1630–1635.
- van Hecke, O., et al. (2014). Neuropathic pain in the general population: A systematic review of epidemiological studies. Pain, 155(4), 654–662.
- Baron, R., Binder, A., & Wasner, G. (2010). Neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurology, 9(8), 807– 819.
- Colloca, L., et al. (2017). Neuropathic pain. Nature Reviews. Disease Primers, 3, 17002.
- van Hecke, O., et al. (2015). Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies: A NeuPSIG systematic review, Delphi survey, and expert panel recommendations. Pain, 156(11), 2337– 2353.
- Finnerup, N. B., et al. (2016). Neuropathic pain: An updated grading system for research and clinical practice. Pain, 157(8), 1599–1606.
- Maier, C., et al. (2010). Quantitative sensory testing in the German research network on neuropathic pain (DFNS): Somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain, 150(3), 439–450.
- Westermann, A., et al. (2011). Pain-associated mild sensory deficits without hyperalgesia in chronic non-neuropathic pain. The Clinical Journal of Pain, 27(9), 782–789.
- Backonja, M. M., et al. (2013). Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain, 154(9), 1807– 1819.
- Cruccu, G., et al. (2010). EFNS guidelines on neuropathic pain assessment: Revised 2009. European Journal of Neurology, 17(8), 1010–1018.
- Haanpaa, M., et al. (2011). NeuPSIG guidelines on neuropathic pain assessment. Pain, 152(1), 14–27.
- Lauria, G., et al. (2010). European Federation of Neurological Societies/ peripheral nerve society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur.J.Neurol., 17(7), 903–909.
- Garcia-Larrea, L., et al. (2002). Laser-evoked potential abnormalities in central pain patients: The influence of spontaneous and provoked pain. Brain, 125(Pt 12), 2766–2781.
- Valeriani, M., et al. (2012). Clinical usefulness of laser evoked potentials.
Neurophysiologie Clinique, 42(5), 345–353.
- Omori, S., et al. (2017). Pain-related evoked potentials after intraepidermal electrical stimulation to Adelta and C fibers in patients with neuropathic pain. Neuroscience Research, 121, 43–48.
- Hansen, N., et al. (2015). Amplitudes of pain-related evoked potentials are useful to detect small fiber involvement in painful mixed fiber neuropathies in addition to quantitative sensory testing - an electrophysiological study. Frontiers in Neurology, 6, 244.
- Cruzat, A., Qazi, Y., & Hamrah, P. (2017). In vivo confocal microscopy of corneal nerves in health and disease. The Ocular Surface, 15(1), 15–47.
- Ziegler, D., et al. (2014). Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes, 63(7), 2454–2463.
- Chen, X., et al. (2015). Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: Comparing corneal confocal microscopy with intraepidermal nerve fiber density. Diabetes Care, 38(6), 1138–1144.
- Weidner, C., et al. (2000). Acute effects of substance P and calcitonin gene- related peptide in human skin--a microdialysis study. The Journal of Investigative Dermatology, 115(6), 1015–1020.
- Fuller, R. W., et al. (1987). Sensory neuropeptide effects in human skin. British Journal of Pharmacology, 92(4), 781–788.
- Kramer, H. H., et al. (2004). Electrically stimulated axon reflexes are diminished in diabetic small fiber neuropathies. Diabetes, 53(3), 769–774.
- Bickel, A., et al. (2009). C-fiber axon reflex flare size correlates with epidermal nerve fiber density in human skin biopsies. Journal of the Peripheral Nervous System, 14(4), 294–299.
- Kalliomaki, M., et al. (2011). Structural and functional differences between neuropathy with and without pain? Experimental Neurology, 231(2), 199–206.
- Schley, M., et al. (2012). Skin innervation at different depths correlates with small fibre function but not with pain in neuropathic pain patients. European Journal of Pain, 16(10), 1414–1425.
- Bickel, A., et al. (2002). Assessment of the neurogenic flare reaction in small- fiber neuropathies. Neurology, 59(6), 917–919.
- Green, A. Q., Krishnan, S. T., & Rayman, G. (2009). C-fiber function assessed by the laser doppler imager flare technique and acetylcholine iontophoresis. Muscle & Nerve, 40(6), 985–991.
- Koppert, W., et al. (2004). Mechanically induced axon reflex and hyperalgesia in human UV-B burn are reduced by systemic lidocaine. European Journal of Pain, 8(3), 237–244.
- Krishnan, S. T., & Rayman, G. (2004). The LDIflare: A novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes. Diabetes Care, 27(12), 2930–2935.
- Kubasch, M. L., et al. (2017). Laser Doppler assessment of vasomotor axon reflex responsiveness to evaluate neurovascular function. Frontiers in Neurology, 8, 370.
- Unal-Cevik, I. (2018). Temporal and spatial quantification of pain- related small fiber functionality assessed using laser speckle contrast analysis. Pain Practice, 18(7),:824–838.
- Freynhagen, R., et al. (2006). painDETECT: A new screening questionnaire to identify neuropathic components in patients with back pain. Current Medical Research and Opinion, 22(10), 1911–1920.
- Bouhassira, D., et al. (2005). Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain, 114(1–2), 29–36.
- Bennett, M. (2001). The LANSS pain scale: The Leeds assessment of neuropathic symptoms and signs. Pain, 92(1–2), 147–157.
- Bouhassira, D., et al. (2004). Development and validation of the neuropathic pain symptom inventory. Pain, 108(3), 248–257.
- Galer, B. S., & Jensen, M. P. (1997). Development and preliminary validation of a pain measure specific to neuropathic pain: The neuropathic pain scale. Neurology, 48(2), 332–338.
- Chaparro, L. E., et al. (2012). Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database of Systematic Reviews, (7), Cd008943.
- Wiffen, P. J., et al. (2017). Gabapentin for chronic neuropathic pain in adults.
Cochrane Database of Systematic Reviews, 6, Cd007938.
- Finnerup, N. B., et al. (2015). Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis. Lancet Neurology, 14(2), 162– 173.
- Waldfogel, J. M., et al. (2017). Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life: A systematic review. Neurology, 88(20), 1958–1967.
- Wiffen, P. J., et al. (2014). Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews, (4), Cd005451.
- Griebeler, M. L., et al. (2014). Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis. Annals of Internal Medicine, 161(9), 639– 649.
- Thomas, A. M., & Atkinson, T. J. (2018). Old friends with new faces: Are Sodium Channel blockers the future of adjunct pain medication management? The Journal of Pain, 19(1), 1–9.
- Zhou, M., et al. (2017). Oxcarbazepine for neuropathic pain. Cochrane Database of Systematic Reviews, 12, Cd007963.
- Snedecor, S. J., et al. (2014). Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy. Pain Practice, 14(2), 167–184.
- Demant, D. T., et al. (2014). The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotype-stratified study. Pain, 155(11), 2263–2273.
- Sindrup, S. H., et al. (2017). Impact of etiology and duration of pain on pharmacological treatment effects in painful polyneuropathy. European Journal of Pain, 21(8), 1443–1450.
- Min, K., et al. (2016). Symptom-based treatment of neuropathic pain in spinal cord-injured patients: A randomized crossover clinical trial. American Journal of Physical Medicine & Rehabilitation, 95(5), 330–338.
- Holbech, J. V., et al. (2016). Pain phenotype as a predictor for drug response in painful polyneuropathy-a retrospective analysis of data from controlled clinical trials. Pain, 157(6), 1305–1313.
- Thienel, U., et al. (2004). Topiramate in painful diabetic polyneuropathy: Findings from three double-blind placebo-controlled trials. Acta Neurologica Scandinavica, 110(4), 221–231.
- Wiffen, P. J., et al. (2013). Topiramate for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews, (8), Cd008314.
- Wiffen, P. J., et al. (2013). Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews. Cochrane Database of Systematic Reviews, (11), Cd010567.
- Wiffen, P. J., Derry, S., & Moore, R. A. (2013). Lamotrigine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews, (12), Cd006044.
- Hearn, L., Derry, S., & Moore, R. A. (2012). Lacosamide for neuropathic pain and fibromyalgia in adults. Cochrane.Database.Syst.Rev., 2, CD009318.
- Birse, F., Derry, S., & Moore, R. A. (2012). Phenytoin for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews, (5), Cd009485.
- Saudek, C. D., Werns, S., & Reidenberg, M. M. (1977). Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clinical Pharmacology and Therapeutics, 22(2), 196–199.
- Chadda, V. S., & Mathur, M. S. (1978). Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. The Journal of the Association of Physicians of India, 26(5), 403–406.
- Moore, R. A., et al. (2015). Amitriptyline for neuropathic pain in adults.
Cochrane Database of Systematic Reviews, (7), Cd008242.
- Derry, S., et al. (2015). Nortriptyline for neuropathic pain in adults. Cochrane Database of Systematic Reviews, 1, Cd011209.
- Hearn, L., et al. (2014). Imipramine for neuropathic pain in adults. Cochrane Database of Systematic Reviews, (5), Cd010769.
- Goldstein, D. J., et al. (2005). Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain, 116(1–2), 109–118.
- Raskin, J., et al. (2005). A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Medicine, 6(5), 346–356.
- Wernicke, J. F., et al. (2006). A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology, 67(8), 1411–1420.
- Sultan, A., et al. (2008). Duloxetine for painful diabetic neuropathy and fibromyalgia pain: Systematic review of randomised trials. BMC Neurology, 8, 29.
- Ney, J. P., et al. (2013). Comparative efficacy of oral pharmaceuticals for the treatment of chronic peripheral neuropathic pain: Meta-analysis and indirect treatment comparisons. Pain Medicine, 14(5), 706–719.
- Kajdasz, D. K., et al. (2007). Duloxetine for the management of diabetic peripheral neuropathic pain: Evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel- group studies. Clinical Therapeutics, 29(Suppl), 2536–2546.
- Boyle, J., et al. (2012). Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: Impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care, 35(12), 2451–2458.
- Lunn, M. P., Hughes, R. A., & Wiffen, P. J. (2014). Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database of Systematic Reviews, (1), Cd007115.
- Lindner, V., & Deuschl, G. (2004). Antidepressants and anticonvulsive agents. Practical utility profile in pain therapy. Schmerz, 18(1), 53–60.
- Derry, S., et al. (2015). Milnacipran for neuropathic pain in adults. Cochrane Database of Systematic Reviews, (7), Cd011789.
- Gallagher, H. C., et al. (2015). Venlafaxine for neuropathic pain in adults.
Cochrane Database of Systematic Reviews, (8), Cd011091.